-
ViiV Healthcare receives NICE recommendation for HIV prevention therapy
22 Oct 2025 12:29 GMT
… by GSK and Pfizer, with Shionogi joining as a shareholder in 2024, ViiV Healthcare … focuses on developing innovative treatments for HIV and AIDS. The … long-acting formulation of Apretude is manufactured at GSK …
-
HBV Reactivation Risk Low After Tenofovir Cessation in HIV
22 Oct 2025 14:25 GMT
… HIV Cohort Study has reported.
Presenting the findings at the European AIDS … antigen [HBsAg]-negative people with HIV and their physicians that switching … in infectious diseases/HIV medicine at the Royal Free … AbbVie, Gilead Sciences, MSD, and ViiV/GSK.
-
Global Fund welcomes renewed commitment from GSK and ViiV Healthcare to expand community-led health solutions with £6 million joint pledge ahead of 8th Replenishment
20 Oct 2025 20:47 GMT
… The Global Fund to Fight AIDS, Tuberculosis and Malaria (the … GSK) and ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer … 70 million people from AIDS, TB and malaria since … and solidarity to end AIDS, TB and malaria, …
-
Which Regimen Works Best for Late-Diagnosis HIV Care?
21 Oct 2025 13:56 GMT
… treatment‑naive patients with HIV infection from July 2019 … and/or an AIDS-defining condition, of whom … -diagnosed people living with HIV when appropriate selection criteria … Gilead Sciences, GSK, MSD, Johnson & Johnson, and ViiV Healthcare. Several …
-
GSK and ViiV pledge £6 million to boost community-led health efforts
21 Oct 2025 09:19 GMT
… from GSK and ViiV Healthcare to strengthen community-led responses to HIV, … 70 million people from AIDS, TB and malaria since … to care and ultimately ending AIDS, TB and malaria – … – £6 million from GSK and ViiV Healthcare – will activate this matching …
-
<![CDATA[ViiV Healthcare Announces 96-Week PASO DOBLE Results Showing Dovato as Effective as Biktarvy in Maintaining Viral Suppression ]]>
19 Oct 2025 10:38 GMT
… Biktarvy) in adults with HIV. Participants taking Dovato also … AIDS Clinical Society (EACS) Congress in Paris.
“For people living with HIV … greater than 5%.
Reference
ViiV Healthcare announces 96-week data … of HIV-1 with significantly less weight gain. ViiV …
-
Europe Has the Tools — So Why Are HIV Targets Off Track?
20 Oct 2025 16:16 GMT
… leaders warned at the European AIDS Clinical Society (EACS) 2025 … friends, and half avoid healthcare
Among healthcare workers, 6 in 10 … an unauthorized disclosure of HIV status, and 20% saw … Janssen-Cilag, Roche, and ViiV/GSK.
*Editor’s note: Except …
-
ONYX comes home for Blackout 30
22 Oct 2025 15:48 GMT
… groups. Representatives from Gilead and ViiV led health-focused discussions as … Howard Brown Health, Milner Worldwide, ViiV Healthcare and Gilead.
The Sisters of …
-
Injectable PrEP is coming to the UK in a groundbreaking development against HIV
17 Oct 2025 16:52 GMT
… ) – a groundbreaking development against HIV/AIDS.
The rollout marks the first … appeals.
Read next
Produced at GSK’s Barnard Castle facility in … sexually acquired HIV-1 infection.
Julie Guest, general manager at ViiV Healthcare UK …
-
First ever HIV-blocking jab given NHS green light - hailed a 'game-changer' in fight to end the virus
17 Oct 2025 13:29 GMT
… in the world to eliminate HIV transmission by 2030.
Called …
Unlike the current daily HIV-prevention tablets known as PrEP … significant addition to our HIV prevention strategies - giving … Cabotegravir is made by ViiV Healthcare, part of GSK, at its Barnard …
About
© 1995-2025